BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 7, 2017
View Archived Issues
Transfer of U.S. orphan drug designations for CAEL-101 to Caelum
Read More
Novartis exercises option to in-license ECF-843 for ophthalmic indications
Read More
U.S. breakthrough therapy designation for evinacumab in homozygous familial hypercholesterolemia
Read More
Immune-Onc collaborates with University of Texas on cancer immunotherapy
Read More
AnaptysBio initiates first-in-human trial of ANB-019
Read More
Myriad Genetics and BeiGene to develop companion diagnostics for BGB-290
Read More
Innocrin awarded second U.S. fast track designation for seviteronel
Read More
Achillion initiates phase II study of ACH-4471 in paroxysmal nocturnal hemoglobinuria
Read More
Aurinia outlines phase III plans for voclosporin in lupus nephritis
Read More
IBA Molecular and Mallinckrodt Nuclear Medicine create new company Curium
Read More
BioMed Realty and UC San Diego announce plans for new oncology research center
Read More
TRAIL receptor agonist ABBV-621 activity described for solid tumors and hematological cancers
Read More
Asceneuron cleared to begin phase I study of oral tau inhibitor ASN-120290
Read More
Envarsus, tacrolimus retard formulation, shows promise in heart transplantation
Read More
Phase III topline results on Trerief for Parkinsonism accompanying DLB
Read More
BioTime establishes AgeX Therapeutics subsidiary
Read More
Quiet Therapeutics describes tumor targeting with hyaluronic acid-coated lipid nanoparticles
Read More
Nanobiotix completes private placement of shares to support progress with NBTXR-3
Read More
Novel HIF-1 inhibitor, IDF-11774, suppresses tumor growth through regulation of cancer metabolism
Read More
Hefei PreceDo Pharmaceuticals discovers novel FLT-3 inhibitors
Read More
XW Laboratories patents gamma-hydroxybutyric acid prodrugs
Read More
Zhejiang Bossan Pharmaceutical describes new EGFR inhibitors
Read More
GlaxoSmithKline divulges novel anti-HIV compounds
Read More
Indiana University Research and Technology, Assembly Biosciences present HBV core protein modulators
Read More
Neuropilin-2 identified as a marker of prostate cancer-specific survival
Read More